Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer

Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer

Abstract This study aimed to retrospectively evaluate the circulating free DNA (cfDNA) level in patients with locally advanced breast cancer (LABC) having different neoadjuvant chemotherapy (NCT) responses and to investigate whether dynamic changes in cfDNA level could predict the effectiveness of N...

Full description

Bibliographic Details
Main Authors: Ge Ma, Jingyi Wang, Huaxing Huang, Xu Han, Jin Xu, Jordee Selvamanee Veeramootoo, Tiansong Xia, Shui Wang
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Cancer Medicine
Subjects:
apoptosis
biomarkers
breast cancer
neoadjuvant chemotherapy
Online Access:https://doi.org/10.1002/cam4.2906

Internet

https://doi.org/10.1002/cam4.2906

Similar Items